Cravatex Limited

Company Profile

Cravatex Limited had its IPO on under the ticker symbol 509472.

The company operates in the Other sector and Other industry. Cravatex Limited has a staff strength of 0 employees.

Stock update

Shares of Cravatex Limited opened at ₹400.05 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹395 - ₹400.05, and closed at ₹396.9.

This is a -0.03% slip from the previous day's closing price.

A total volume of 970 shares were traded at the close of the day’s session.

In the last one week, shares of Cravatex Limited have increased by +0.77%.

Cravatex Limited's Key Ratios

Cravatex Limited has a market cap of ₹703.67 million, indicating a price to book ratio of 2.8501 and a price to sales ratio of 0.105.

In the last 12-months Cravatex Limited’s revenue was ₹6.74 billion with a gross profit of ₹2.26 billion and an EBITDA of ₹68.11 million. The EBITDA ratio measures Cravatex Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Cravatex Limited’s operating margin was -0.06% while its return on assets stood at 0% with a return of equity of 0%.

In Q2, Cravatex Limited’s quarterly earnings growth was a positive 0% while revenue growth was a negative 67.2%.

Cravatex Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

1120.8

PEG

Its diluted EPS in the last 12-months stands at ₹-44.836 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cravatex Limited’s profitability.

Cravatex Limited stock is trading at a EV to sales ratio of 0.2628 and a EV to EBITDA ratio of 12.6101. Its price to sales ratio in the trailing 12-months stood at 0.105.

Cravatex Limited stock pays annual dividends of ₹5 per share, indicating a yield of 1.84% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹1.37 billion

Total Liabilities

₹426.41 million

Operating Cash Flow

₹424.19 million

Capital Expenditure

₹0

Dividend Payout Ratio

0%

Cravatex Limited ended 2024 with ₹1.37 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.37 billion while shareholder equity stood at ₹923.64 million.

Cravatex Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹426.41 million in other current liabilities, 25842000.00 in common stock, ₹897.79 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹337000.00 and cash and short-term investments were ₹611.64 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.00.

Cravatex Limited’s total current assets stands at ₹1.26 billion while long-term investments were ₹0 and short-term investments were ₹48.42 million. Its net receivables were ₹262.15 million compared to accounts payable of ₹0 and inventory worth ₹290.42 million.

In 2024, Cravatex Limited's operating cash flow was ₹424.19 million while its capital expenditure stood at ₹0.

Comparatively, Cravatex Limited paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹396.9

52-Week High

₹541.7859

52-Week Low

₹283.5459

Analyst Target Price

₹

Cravatex Limited stock is currently trading at ₹396.9 per share. It touched a 52-week high of ₹541.7859 and a 52-week low of ₹541.7859. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹402.55 and 200-day moving average was ₹377.53 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 8521.2% of the company’s stock are held by insiders while 0% are held by institutions.